Study ID: TV48125-CNS-30057 | 2016-003171-21
Study Title
- A Study Comparing the Efficacy and Safety of Fremanezumab (TEV-48125) for the Prevention of Chronic Cluster Headache (CCH)
Teva Identifier
- TV48125-CNS-30057 | 2016-003171-21
ClinicalTrials.gov Identifier
- NCT02964338
Study Status
- Terminated
Trial Condition(s)
- Chronic Cluster Headache
Interventions
- Drug: Fremanezumab | Drug: Placebo
Study Description
- Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
Gender
- Female, Male
Age Range
- 18 Years to 70 Years
Trial Duration
- January 17, 2017 - July 18, 2018
Phase
- Phase 3
Additional info
Study Type
Interventional
